Hikma Pharmaceuticals (HKMPY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    OTC: HKMPY · Real-Time Price · USD
    49.25
    -0.15 (-0.30%)
    At close: Oct 03, 2025, 12:19 PM
    49.25
    0.00%
    Pre-market: Oct 03, 2025, 09:44 AM EDT

    Hikma Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 3.22B 3.13B 3.01B 2.86B 2.79B 2.58B 2.56B 2.57B 2.4B
    Cost of Revenue
    		 1.83B 1.71B 1.63B 1.55B 1.48B 1.38B 1.35B 1.35B 1.25B
    Gross Profit
    		 1.33B 1.37B 1.38B 1.31B 1.31B 1.2B 1.21B 1.22B 1.15B
    Operating Income
    		 493.61M 585.61M 476M 473M 611.29M 518.29M 558.8M 599.8M 559.2M
    Interest Income
    		 7.99M 7.96M 7.97M 6.97M 5.1M 3.1M 19M 19M 4.93M
    Pretax Income
    		 462M 455M 366.37M 280.37M 220.88M 233.88M 441.08M 545.08M 597.91M
    Net Income
    		 369.66M 357.66M 284.53M 189.53M 146.73M 188.73M 347.61M 422.61M 463.08M
    Selling & General & Admin
    		 573.99M 575.99M 694.68M 674.68M 540.07M 536.07M 498.23M 474.23M 461.81M
    Research & Development
    		 152.19M 140.19M 145.32M 148.32M 142.67M 147.67M 153.78M 143.78M 132.66M
    Other Expenses
    		 137.81M 86.81M 63.01M -18.99M -18M n/a n/a n/a n/a
    Operating Expenses
    		 864M 803M 903.01M 840.01M 700.74M 683.74M 652.01M 618.01M 594.46M
    Interest Expense
    		 83.9M 87.56M 86.66M 86.66M 90.15M 79.15M 64.29M 56.29M 54.46M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 2.7B 2.52B 2.53B 2.39B 2.18B 2.06B 2B 1.97B 1.84B
    Income Tax Expense
    		 88.66M 92.66M 76.86M 88.86M 72.05M 42.05M 94.49M 124.49M 135.82M
    Shares Outstanding (Basic)
    		 111.21M 110.32M 111.88M 111.37M 111.02M 110.23M 113.97M 116.98M 116M
    Shares Outstanding (Diluted)
    		 111.21M 111.52M 111.88M 111.37M 111.02M 110.91M 114M 117M 116M
    EPS (Basic)
    		 3.36 3.24 2.58 1.72 1.32 1.66 3.00 3.62 4.02
    EPS (Diluted)
    		 3.32 3.20 2.54 1.70 1.32 1.66 3.00 3.62 4.02
    EBITDA
    		 784.86M 735.86M 641.28M 660.28M 730M 625M 688.2M 769.2M 800.1M
    EBIT
    		 582.88M 539.88M 451.04M 429.04M 374.04M 313.04M 505.37M 601.37M 652.38M
    Depreciation & Amortization
    		 201.98M 195.98M 190.25M 190.25M 197.75M 194.75M 182.83M 167.83M 147.73M

    Add to Watchlist